The Journal of Heart and Lung Transplantation
Volume 29, Issue 4 , Pages 395-400 , April 2010

Antibody-mediated rejection in lung transplantation: Myth or reality?

  • Allan R. Glanville, MBBS, MD, FRACP

      Affiliations

    • Corresponding Author InformationReprint requests: Prof Allan R. Glanville, MD, FRACP, The Lung Transplant Unit, Xavier Level 4, St. Vincent's Hospital, Victoria St, Darlinghurst, NSW 2010, Australia. Telephone: +61-2-8382-3257. Fax: +61-2-8382-3084

References 

  1. Veith FJ, Hagstrom JW. Alveolar manifestations of rejection: an important cause of the poor results with human lung transplantation. Ann Surg. 1972;175:336–348
  2. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004;4:1033–1041
  3. Terasaki PI. Humoral theory of transplantation. Am J Transplant. 2003;3:665–673
  4. Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990;9:593–601
  5. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1996;15:1–15
  6. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229–1242
  7. Shah AS, Nwakanma L, Simpkins C, Williams J, Chang DC, Conte JV. Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients. Ann Thorac Surg. 2008;85:1919–1924
  8. Frost AE, Jammal CT, Cagle PT. Hyperacute rejection following lung transplantation. Chest. 1996;110:559–562
  9. Bittner HB, Dunitz J, Hertz M, Bolman MR, Park SJ. Hyperacute rejection in single lung transplantation—case report of successful management by means of plasmapheresis and antithymocyte globulin treatment. Transplantation. 2001;71:649–651
  10. Masson E, Stern M, Chabod J, et al. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies. J Heart Lung Transplant. 2007;26:642–645
  11. de Jesus Peixoto Camargo J, Marcantonio Camargo S, Marcelo Schio S, Noguchi Machuca T, Adelia Perin F. Hyperacute rejection after single lung transplantation: a case report. Transplant Proc. 2008;40:867–869
  12. Saint Martin GA, Reddy VB, Garrity ER, et al. Humoral (antibody-mediated) rejection in lung transplantation. J Heart Lung Transplant. 1996;15:1217–1222
  13. Badesch DB, Zamora M, Fullerton D, et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant. 1998;17:415–422
  14. Astor TL, Weill D, Cool C, Teitelbaum I, Schwarz MI, Zamora MR. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant. 2005;24:2091–2097
  15. Girnita AL, McCurry KR, Yousem SA, Pilewski J, Zeevi A. Antibody-mediated rejection in lung transplantation: case reports. Clin Transpl. 2006;508–510
  16. Astor TL, Galantowicz M, Phillips A, Palafox J, Baker P. Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation. Am J Transplant. 2009;9:409–412
  17. Morrell MR, Patterson GA, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant. 2009;28:96–100
  18. Jaramillo A, Fernandez FG, Kuo EY, Trulock EP, Patterson GA, Mohanakumar T. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant. 2005;9:84–93
  19. Harjula AL, Baldwin JC, Glanville AR, et al. Human leukocyte antigen compatibility in heart-lung transplantation. J Heart Transplant. 1987;6:162–166
  20. Schulman LL, Weinberg AD, McGregor CC, Suciu-Foca NM, Itescu S. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med. 2001;163:437–442
  21. Chalermskulrat W, Neuringer IP, Schmitz JL, et al. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest. 2003;123:1825–1831
  22. Smith MA, Sundaresan S, Mohanakumar T, et al. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg. 1998;116:812–820
  23. Sundaresan S, Mohanakumar T, Smith MA, et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation. 1998;65:648–653
  24. Quantz MA, Bennett LE, Meyer DM, Novick RJ. Does human leukocyte antigen matching influence the outcome of lung transplantation? (An analysis of 3,549 lung transplantations). J Heart Lung Transplant. 2000;19:473–479
  25. Smith JD, Crisp SJ, Dunn MJ, Pomerance A, Yacoub MH, Rose ML. Pre-transplant anti-epithelial cell antibodies and graft failure after single lung transplantation. Transpl Immunol. 1995;3:68–73
  26. Abdul-Karim AB, Barnes AD, Bevan IS, et al. Anti-epithelial (anti-A549) antibodies: their nature, specificity and relevance to transplantation. Transpl Immunol. 1995;3:192–202
  27. Magro CM, Deng A, Pope-Harman A, et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74:1273–1280
  28. Magro CM, Klinger DM, Adams PW, et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant. 2003;3:1264–1272
  29. Magro CM, Ross P, Kelsey M, Waldman WJ, Pope-Harman A. Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant. 2003;3:1155–1166
  30. Magro CM, Pope Harman A, Klinger D, et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant. 2003;3:1143–1154
  31. Miller GG, Destarac L, Zeevi A, et al. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant. 2004;4:1323–1330
  32. Wallace WD, Reed EF, Ross D, Lassman CR, Fishbein MC. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant. 2005;24:1565–1570
  33. Magro CM, Abbas AE, Seilstad K, Pope-Harman AL, Nadasdy T, Ross P. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol. 2006;67:274–283
  34. Westall GP, Snell GI, McLean C, Kotsimbos T, Williams T, Magro C. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant. 2008;27:722–728

PII: S1053-2498(10)00044-6

doi: 10.1016/j.healun.2010.01.012

The Journal of Heart and Lung Transplantation
Volume 29, Issue 4 , Pages 395-400 , April 2010

Article Tools

* Image Usage & Resolution